Latest News and Press Releases

PsyCan Excoriates Trudeau Government for Making Assisted Suicide Harder than Psychedelic-Assisted Therapy; Calls on Carney and Poilievre to do better

Psycan comments on USFDA's recent decision to request a third phase 3 trial prior to approval of

Psycan announces that Blue Cross Alberta has issued a notice to prescribers that it will reimburse patients for Psychedelic-Assisted Therapy

PsyCan Endorses Senate Report into Psychedelic Treatments for Veterans

PsyCan, the trade association for the for-profit psychedelic medicine industry, releases a white paper on how Health Canada can improve access to therapies